Barbara Withers
Chief Tech/Sci/R&D Officer presso OCUPHIRE PHARMA, INC.
Profilo
Barbara Withers is currently working as VP-Clinical & Regulatory Strategy at Ocuphire Pharma, Inc. She has previously worked as Project Director & Site Head at United BioSource Corp., Project Manager-Drug Development at Pfizer Inc., and Vice President-Clinical Operations at Aerpio Pharmaceuticals, Inc. Ms. Withers has an undergraduate degree from the University of Michigan and a doctorate degree from The Wayne State University School of Medicine.
Posizioni attive di Barbara Withers
| Società | Posizione | Inizio |
|---|---|---|
| OCUPHIRE PHARMA, INC. | Chief Tech/Sci/R&D Officer | - |
Precedenti posizioni note di Barbara Withers
| Società | Posizione | Fine |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | - |
United BioSource Corp.
 United BioSource Corp. Miscellaneous Commercial ServicesCommercial Services United BioSource Corp. is a scientific and medical affairs organization that partners with life science companies to develop and commercialize their products. The company is involved in pre- and post-approval product development; pricing, coverage, reimbursement, and access strategies; and medical publication and communications. United BioSource Corp. was founded by Ethan D. Leder and Mark P. Cleinin in 2003 and is headquartered in Chevy Chase, MD. | Corporate Officer/Principal | - |
| AERPIO PHARMACEUTICALS | Corporate Officer/Principal | - |
Formazione di Barbara Withers
| University of Michigan | Undergraduate Degree |
| The Wayne State University School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| OCUPHIRE PHARMA, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
United BioSource Corp.
United BioSource Corp. Miscellaneous Commercial ServicesCommercial Services United BioSource Corp. is a scientific and medical affairs organization that partners with life science companies to develop and commercialize their products. The company is involved in pre- and post-approval product development; pricing, coverage, reimbursement, and access strategies; and medical publication and communications. United BioSource Corp. was founded by Ethan D. Leder and Mark P. Cleinin in 2003 and is headquartered in Chevy Chase, MD. | Commercial Services |
Aerpio Pharmaceuticals, Inc.
 Aerpio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Pharmaceuticals Inc. is a biopharmaceutical company, which engages in the research and development of treatments for ocular diseases. The firm's product candidate is AKB-9778, a small molecule activator of the Tie2 pathway, which completed the Phase 2a clinical trial for the treatment of diabetic retinopathy. It also develops ARP-1536, a humanized monoclonal antibody that is in preclinical development stage for the treatment of diabetic vascular complications; and AKB-4924, a selective stabilizer of hypoxia-inducible factor-1 alpha, which has completed a single ascending dose clinical trial for the treatment of inflammatory bowel disease. The company was founded by Joseph H. Garder on November 16, 2007 and is headquartered in Cincinnati, OH. | Health Technology |
- Borsa valori
- Insiders
- Barbara Withers
